A Theranos sign outside the company's headquarters
Theranos Founder Elizabeth Holmes Convicted of Fraud
After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.
Theranos Founder Elizabeth Holmes Convicted of Fraud
Theranos Founder Elizabeth Holmes Convicted of Fraud

After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.

After a week of deliberation, a jury returned a guilty verdict on four charges related to wire fraud, each of which carries a maximum sentence of up to 20 years in prison.

industry
Shot of a young woman using a computer while working in a laboratory
Pandemic Amplifies Postdoc Struggles
Bianca Nogrady | Dec 28, 2021 | 5+ min read
Postdoctoral fellows faced challenges before COVID-19 changed the way academia functions, and these early career scientists report that things have only gotten harder.
Top 10 Innovations 2021
2021 Top 10 Innovations
The Scientist Staff | Dec 1, 2021 | 5+ min read
The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.
Black-and-white headshot of Aubrey de Grey
Aubrey de Grey on Leave After Sexual Harassment Allegations
Jef Akst | Aug 11, 2021 | 2 min read
Last night, two women publicly accused the famed anti-aging researcher of inappropriately bringing up sex in the workplace, and they say they are not his only victims.
Women looks at computer screen in a lab coat and mask
Quest for Research Freedom Fuels African Biotech Boom
Linda Nordling | Jul 1, 2021 | 5+ min read
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
New Drug Combo for ALS Slows Decline in Small Clinical Study
Jef Akst | Sep 3, 2020 | 3 min read
After six months, patients with fast-progressing amyotrophic lateral sclerosis who had received the experimental treatment had less loss of function than those who received a placebo.
COVID-19, SARS-CoV-2, coronavirus, pandemic, transmission, superspread, genome, virus, tracking, Biogen, Massachusetts
Thousands of Coronavirus Infections Stemmed from a Biotech Event
Amanda Heidt | Aug 26, 2020 | 3 min read
Officials had initially linked 97 cases to a single conference held by Biogen in February in Boston, but a new study tracking viral genomes suggests the number may be as high as 20,000.
It Takes Less Than 30 Days to Compost a Human Body
Jef Akst | Feb 17, 2020 | 2 min read
In a small trial of deceased volunteers, a Seattle-based company called Recompose demonstrates that its method for “natural organic reduction” of a human body completely breaks down soft tissue.
technology transfer patent licensing academic research federal grant patent innovation
Opinion: Taxpayers Should Cover Portion of Patent Costs
Paul R. Sanberg | Oct 9, 2019 | 4 min read
Federal grant support for technology transfer at universities will strengthen the national innovation system.
California Seeks to Ban Chlorpyrifos-Containing Pesticides
Jef Akst | May 9, 2019 | 2 min read
The state’s Environmental Protection Agency says that evidence of the chemical’s link to neurological problems in children is overwhelming.
april 2019 editorial the scientist
Miracle Elixirs
Bob Grant | Apr 1, 2019 | 3 min read
A long way into the quest to vanquish cancer, our ears strain to hear the words, “Cancer is cured”—a yearning that can cloud our judgment.
Industry Partners Extensively Involved in Trials They Fund
Catherine Offord | Oct 5, 2018 | 2 min read
A new study suggests that sponsors downplay their influence when reporting trials carried out in collaboration with academic researchers.
Blue Rush: One Company Leads the Race to Own Marine Genetic Sequences
Ruth Williams | Jun 6, 2018 | 3 min read
Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  
How to Successfully Collaborate with Industry
Ashley P. Taylor | Mar 1, 2018 | 5+ min read
In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.
Can Young Stem Cells Make Older People Stronger?
Shawna Williams | Dec 11, 2017 | 4 min read
Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 
Editors Claim Censorship at a Public Health Journal
Jef Akst | Nov 21, 2017 | 2 min read
The editorial board at the International Journal of Occupational and Environmental Health accuses its publisher of promoting corporate interests.
2017 Life Science Salary Survey
Aggie Mika | Nov 1, 2017 | 5+ min read
Industry professionals make more than academic researchers, but for professors, it may not be about the money.
Opinion: Tales from the Nonacademic Career Path
Anna Kriebs | Sep 2, 2017 | 4 min read
Graduate students from The Scripps Research Institute share how they prepared to enter policy, law, biotech, and beyond.
Gilead to Pay Nearly $12B for CAR T-Cell Company
Jef Akst | Aug 28, 2017 | 2 min read
The massive sum will buy out Kite Pharma, whose cancer therapy is expected to be among the first of its type approved by the FDA.